Theme: Hematology: New Insights into Diagnosis and Treatment
World Hematology 2018
Conference Series LLC LTD invites each one all through the world attend "15th World Hematology & Immunology Congress" amid December 05-06, 2018 in Lisbon, Portugal working under the Theme: Hematology: New Insights into Diagnosis and Treatment which fuses incite keynote introductions, Oral talks, Poster introductions and Exhibitions.
The principle point of World Hematology 2018 is to investigate the new bits of knowledge into the analysis and treatment in the field of hematology to every one of the hematologists, analysts, educators and youthful inquires about gathering.
World Hematology 2018 is to get-together individuals in the scholarly world and society inspired by hematology to share the most recent patterns and imperative issues pertinent to our field/branch of knowledge. The logical program of the gathering is expansive and grasps distinctive research perspectives with centre around determination, treatment and aversion specifically with a Tumour and therapeutic intrigue. The gathering will incorporate welcomed speakers, oral introductions, blurb session and the youthful researcher grant.
Why to attend??
15th World Hematology & Immunology Congress during December 05-06, 2018 at Lisbon, Portugal is a unique platform to share the knowledge on current research. With individuals from around the globe concentrated on finding out about Hematology and its advances; this is your best chance to achieve the biggest collection of members from the Hematology people group. Direct introductions, convey data, meet with present and potential researchers, make a sprinkle with new medication improvements, and get name acknowledgment at this 2-day occasion. Incredibly famous speakers, the latest strategies, advancements, and the most current updates in Hematology are signs of this gathering.
Target Audience
- Hematology Students, Scientists
- Hematology Faculty
- Hematology Researchers
- Medical Colleges
- Pathologists
- Immunologists
- Business Entrepreneurs
- Hematology Associations and Societies
- Training Institutes
- Manufacturing Medical Devices Companies
Track 1: Immunohematology:
Immunohematology is commonly referred as “Blood banking” is a branch of haematology that deals with the study of antigen-antibody reactions associated with blood transfusion. A person employed in the field of Immunohaematology is referred to as Immunohematologist. This is the zone of lab medication that deals with preparing blood and blood components for transfusion and in addition determination of proper, perfect segments for transfusion.
The responsibilities of Immunohaematologist include:
- Blood typing
- Cross matching
- Antibody identification
Related Conferences:
Blood Disorders Congress 2018 | World Hematology Conferences | Hematologic Oncology Meet | Hematologists Meetings
25th Biennial European Association for Cancer Research Conference June 30-July3 2018 Amsterdam; 27th International Oncology research Conference and Cancer Stem Cells Conference May 10-12, 2018 | Frankfurt, Germany | 12th World Hematology Conference March 15-16, 2018 | London, UK;
Hematology Societies in Europe
Association of European Cancer Leagues, Europe; International Society of Pediatric Oncology, Europe; European Academy of Cancer Sciences, Europe; European Society of Surgical Oncology, Europe; Organization of European Cancer Institute, Europe; European Organization for Research and Treatment of Cancer, Europe; European Prostate Cancer Coalition, Europe
Track 2: Leukocytosis:
Leukocytosis refers to increase in the total number of white blood cells above the normal range in the blood. It is frequently a sign of an inflammatory response, most commonly due to infection. Leukocytosis is very commonly seen in the people with less immunity. Symptoms include: parasitic, fungal, viral or bacterial infection, hemorrhage, cancer and exposure to certain medications or chemicals including steroids.
There are five major types of Leukocytosis:
- Neutrophilia
- Lymphocytosis
- Monocytosis
- Eosinophilia
- Basophilia
Related Conferences:
World Hematology Congress | Blood Cancer Event 2018 | Hematology Experts Conferences | Immunohematology Conferences
28th Euro Cancer Science Conference and Cancer Therapy Conference August 09-10, 2018 | Madrid, Spain; 11th European Breast Cancer Conference Mar 21- 23, 2018 | Barcelona, Spain
Hematology Societies in Europe
British Society for Haematology, Europe; European Cancer Organization: ECCO, Europe; ESMO: European Society for Medical Oncology, Europe; European Association for Cancer Research, Europe; Egyptian Society of Hematology and Research
Track 3: Thrombocytopenia:
Deficiency of thrombocytes (platelets) in the blood is referred as thrombocytopenia. It may occur due to decreased production, increased destruction, medication induced and other causes such as snakebite, lyme disease, thrombocytapheresis, niacin toxicity. It can be diagnosed by complete blood test, kidney function test, liver enzymes, vitamin B12 levels and erythrocyte sedimentation rate (ESR).
Types of thrombocytopenia:
- Idiopathic (or immune) thrombocytopenic purpura (ITP)
- Thrombotic thrombocytopenic purpura (TTP)
- Haemolytic uraemic syndrome (HUS)
Related Conferences:
Pediatric Oncologist Congress | Hematology Congress | Hematology Experts Meeting | Blood Diseases Summit
ESMO Sarcoma and GIST Symposium 2018 February 5-7, 2018 | Milan, Italy; 4th Annual on Gynecologic Oncology Conference July 18-19, 2018 | Atlanta, USA; ASH Meeting on Hematologic Malignancies September 7-8, 2018 | Chicago, IL; Genitourinary Cancers Symposium February 8-10, 2018 | California, USA
Hematology Societies in USA
American Brain Tumor Association, USA; American Society for Radiation Oncology, USA; Association of Community Cancer Centers, USA; American Childhood Cancer Organization, USA; Michigan Society of Hematology and Oncology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; Childhood Brain Tumor Foundation, USA; Lymphoma Research Foundation; American Cancer Society, USA
Track 4: Myeloma:
Multiple myeloma or plasma cell myeloma is a cancer that arises from plasma cells (mature lymphocytes) a type of white blood cells. In myeloma plasma cells become abnormal, proliferate and from tumours that accumulate in the different parts of the body especially in the bone marrow and over the surface of bones. These cells discharge only single type of antibody known as paraprotein (which do not exhibit any useful function). Myeloma is diagnosed and monitored by measuring the levels of paraproteins.
Signs and symptoms include:
- Bone pain
- Anemia
- Kidney failure
- Infection
- Neurologica symptoms
Related Conferences:
Hematology Malignancies conference | Hematologists Conferences | Bleeding disorders Meetings | World Hematology Congress 2018
ASH Meeting on Lymphoma Biology August 2-5, 2018 | Washington, DC; ASH Summit on Emerging Immunotherapies for Hematologic Diseases July 12-13, 2018 | Washington, DC; Aga Khan University Joint Session - Surgical Oncology - Evidence & Practice February 2-3, 2018 | Karachi, Pakistan
Hematology Societies in USA
American Head and Neck Society, USA; Foundation for Women's Cancer, USA; Canadian Hematology Society, USA; Colon Cancer Alliance, USA; International Society for Laboratory Hematology, USA; International Society of Hematology, USA; Lung Cancer Foundation of America, USA; Mexican Society of Hematology, USA; American Society of Clinical Oncology, USA; Children's Tumor Foundation, USA
Track 5: Blood Transfusion:
It is a medical procedure in which donated blood is transfused to a recipient. It is a lifesaving, safe procedure. Transfusions are used to treat various medical conditions such as iron deficiency anemia, sickle cell disease, severe bleeding- usually from surgery, childbirth or a serious accident. Either whole blood or blood components (red blood cells, white blood cells, plasma and clotting factors) are used depending on the condition of the patient.
Adverse effects:
- Immunologic reaction
- Infection
- Inefficacy
Related Conferences:
Pediatric Hematologist Conferences | Hematology Congress 2018 | Blood conferences | Hematology Events | Blood Diseases Meet
ESMO Africa Cancer Conference February 14-16, 2018 | Cape Town, South Africa; Hematology Global Summit 2018 September 20-21, 2018 | Bali, Indonesia; World Hematology Conference and Medical Oncology Conference May 28-30, 2018 | Osaka, Japan; Surgical Oncology- Evidence & Practice February 2-3 2018 | Karachi, Pakistan
Hematology Societies in Asia-Pacific
Asian Cancer Foundation, Asia-Pacific; Asia Pacific Hematology Consortium, Asia-Pacific; Asian Society of Gynecologic Oncology, Asia-Pacific; Cancer Therapeutics Research Group, Asia-Pacific; Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific; Asian Hematology Association, Asia-Pacific
Track 6: Anemia:
Decrease in haemoglobin level or red blood cells count in blood leads to Anaemia. The symptoms include: Irritability, Palpitations, Breathlessness, Tingling, Glossitis (inflammation or infection of the tongue), Angina, Angular cheilitis (inflammatory lesions at the mouth's corners), Poor appetite, Dysphagia due to formation of esophageal webs (Plummer-Vinson syndrome), numbness, or burning sensations, Restless legs syndrome. If left untreated it leads to heart failure, arrhythmias and frequent infections.
- Aplastic anemia
- Iron deficiency anemia
- Vitamin deficiency anemia
- Hemolytic anemias
- Anemia of chronic disease
- Anemias associated with bone marrow disease
- Sickle cell anemia
Related Conferences:
Hematology Conferences | Hematologic Oncology Meet | Blood Conferences | World Hematology Events
4th World cancer Conference and Cancer Prevention Methods Conference April 19-21, 2018 | Valencia, Spain; Global Oncology Conference & Cancer Conference March 14-16, 2018 | Singapore; Global Oncology Conference and Radiology Conference April 16-17, 2018 | Dubai, UAE
Hematology Societies in Asia-Pacific
The Thai Society of Hematology, Asia-Pacific; Asian and Pacific Federation of Organizations for Cancer Research and Control, Asia-Pacific; Asian Clinical Oncology Society: ACOS, Asia-Pacific; Asian Fund for Cancer Research, Asia-Pacific; Australasian Lung Cancer Trials Group, Asia-Pacific; Japanese Society of Hematology, Asia-Pacific; Pan Arab Hematology Association, Asia-Pacific;
Track 7: Thrombosis:
Thrombosis is the formation of blood clot in the blood vessel. Thrombosis is generally classified by the type of blood vessel affected and the precise location of the blood vessels or the organ supplied by it. The treatment of thrombosis depends on the type of blood vessel whether it is in a vein or an artery, person’s impact and the risk of complications from treatment.
Thrombosis is classified into 3 types:
- Venous thrombosis
- Arterial thrombosis
- Limb ischemia
Related Conferences:
Immunohematology Conferences 2018 | Blood Congress | Hematology Meetings | Blood Cancer Events | Hematology Nursing Meet
25th Biennial European Association for Cancer Research Conference June 30-July 2018 Amsterdam; 12th World Hematology Conference March 15-16, 2018 | London, UK; 27th International Oncology research Conference and Cancer Stem Cells Conference May 10-12, 2018 | Frankfurt, Germany
Hematology Societies in South Africa
World Health Organisation - Africa Region; Africa Cancer Foundation, Africa; Afrox - Improving Cancer Care in Africa; Oncology for Africa ONLUS - Afron, Africa; South African Clinical Haematology Society, Africa; African Organization for Research and Training in Cancer, Africa
Track 8: Biomarkers in Hematology and Oncology:
A cancer biomarker is a gene or substance that reveal the presence of cancer in the body that are particularly associated with genetic mutations, which determine whether individuals are susceptible to particular type of cancer.
- Genetic markers
- Tumour markers
- Cancer biomarkers
- Diagnostic Biomarker
- Biomarker Discovery
Related Conferences:
Blood Disorders Conferences 2018 | Hematology Conferences | World Hematology Congress 2018 | Hematologist oncologist Meet
11th European Breast Cancer Conference Mar 21- 23, 2018 | Barcelona, Spain; 28th Euro Cancer Science Conference and Cancer Therapy Conference August 09-10, 2018 | Madrid, Spain
Hematology Societies in South Africa
CHOC Childhood Cancer Foundation, South Africa; African Cancer Registry Network, Africa; African Journal of Cancer | Mediterranean Oncology Society, Africa; South African Society of Haematology, Africa; African Women’s Cancer Awareness Association, Africa; Haematology and Oncology Society of Africa; Morocco - World Health Organization Africa
Track 9: HIV/AIDS:
Human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS). It harms the immune system by destroying the white blood cells that fight infection. A person with HIV infection may not notice any symptoms at the initial stage, followed by no symptoms for prolonged period. As the infection progress, there will be an increasing risk of common infections like tuberculosis and other opportunistic infections. Thrombocytopenia is often associated with HIV infection. HIV and SIV-associated thrombocytopenia arise through multiple mechanisms, including decreased platelet production, increased platelet destruction due to HIV-mimetic anti-platelet antibodies, and increased use of activated platelets.
HIV is transmitted through three main routes:
- Sexual
- Body fluids
- Mother-to-child
Related Conferences:
World Hematology 2018 | Pediatric Hematology Meeting | Global Hematology Events | Blood Cancer Conferences
2nd International Autoimmunity Conferences, November 06-07, 2017 Frankfurt, Germany; 12th World Hematology Conferences, March 15-16, 2018 London, UK; 9th International Conferences on Leukemia and Hematologic Oncology Conferences, October 05-06, 2017 London, UK
European Hematology Societies:
International society of Hematology, European society of Hematology, British Society of Hematology, European society of Pediatric Hematology Oncology
Track 10: Lymphoma:
Lymphoma is a group of blood cancers that results from white blood cells called lymphocytes. The two major types of lymphomas are Hodgkin’s lymphoma and non-Hodgkin’s lymphoma. There are two major types of Hodgkin lymphoma: classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma. The most common symptom include: swelling of lymph nodes, which causes a lump to form under the skin. Other symptoms of HD include night sweats, itchy skin, fever, fatigue, unintended weight loss, persistent cough, trouble breathing, chest pain, pain in the lymph nodes, after consuming alcohol, enlarged spleen.
- Radiation Therapy
- Targeted Therapy
- Chemotherapy
Related Conferences:
World Hematology 2018 | Bleeding disorders Event | Heme-Oncology Congress | Pediatric Hematology Conferences
9th European Immunology Conferences, June 14-16, 2018 Rome, Italy; 9th Molecular Immunology Conferences & Immunogenetics Conferences, March 08-09, 2018 London, UK; 27th International Conference on Oncology & Cancer Stem Cells Conferences, May 10-12, 2018 Frankfurt, Germany; 28th Euro Cancer Science Conferences, August 09-10, 2018 Madrid, Spain
USA Hematology Societies:
The Canadian Hematology Society, American Society of Hematology, International Society for Laboratory Hematology, Michigan society of Hematology, American Society of Clinical Oncology
Track 11: Hemochromatosis:
Hemochromatosis is a disease where excess iron is accumulated in the body by any cause. Commonly affected organs by hemochromatosis are heart, endocrine glands and liver. It can be diagnosed by Ferritin test, Liver function test, Iron test, UIBC, TIBC and Transferrin test. Hemochromatosis may present with the following clinical syndromes: Liver Cirrhosis, Arthritis, Testicular Failure, Joint and bone pain and Cardiomyopathy.
Types of Hemochromatosis:
- Haemochromatosis type 1: "classical" haemochromatosis
- Haemochromatosis type 2A: juvenile haemochromatosis
- Haemochromatosis type 2B: juvenile haemochromatosis
- Haemochromatosis type 3
- Haemochromatosis type 4
- Congenital atransferrinaemia (very rare)
- Acaeruloplasminaemia (very rare)
- GRACILE syndrome (very rare)
- Neonatal haemochromatosis
Related Conferences:
Blood Disorders Congress | Hematology Nursing Events | Blood Cancer Summit | Pediatric Hematology Meeting
12th Dutch Hematology Conferences, January 24-26, Arnhem, Netherlands; ESMO Immuno Oncology Conferences 2017, December 07-10, 2017, Geneva, Switzerland; The 2nd International Conference on Clinical Trials in Oncology and Hemato-Oncology Conferences, February 19-20, Berlin, Germany; 59th American Society of Hematology Conferences, December 9-12, 2017, Atlanta, GeorgiaAsian
Hematology Societies:
Haematology Society of Australia and New Zealand, Emirates society of Hematology, Armenian Hematology Association, Saudi Society for Hematology, Malaysian society of Hematology
Track 12: Stem Cell Therapy:
Stem cell therapy is the treatment where stem cells are used to prevent a disease or condition. Haematopoietic stem cells are usually derived from bone marrow, or peripheral blood. Bone marrow transplantation is widely used stem cell therapy. It may be autologous, allogeneic or syngeneic.
Applications of Stem Cell Therapy:
- Brain and spinal cord injury
- Neurodegeneration
- Blood cell formation
- Pancreatic beta cells
- Orthopaedics
- Wound healing
- Infertility
Related Conferences:
Pediatric Oncologist Congress | Bleeding disorders Event | Heme-Oncology Meeting | Blood Cancer Summit
25th Biennial European Association for Cancer Research Conference June 30-July3 2018 Amsterdam; 12th World Hematology Conference March 15-16, 2018 | London, UK; 27th International Oncology research Conference and Cancer Stem Cells Conference May 10-12, 2018 | Frankfurt, Germany
Hematology Societies in Europe
European Society of Surgical Oncology, Europe; Association of European Cancer Leagues, Europe; European Academy of Cancer Sciences, Europe; European Prostate Cancer Coalition, Europe; Organization of European Cancer Institute, Europe; European Organization for Research and Treatment of Cancer, Europe; International Society of Pediatric Oncology, Europe
Track 13: Blood Tests:
A scientific examination of a sample of blood, generally advised by the physician for the diagnosis of illness, for the detection and measurement of drugs, assess your general state of health, to assess the functioning of the certain organs such as liver and kidneys.
Types of blood test:
- Complete Blood Count
- Kidney Test: Renal Profile
- Cholesterol Test: Lipid Profile
- Blood Glucose Test
- Liver Function Test
- Blood Clotting Test
Related Conferences:
World Hematology 2018 | Pediatric Hematology Meeting | Global Hematology Events | Blood Cancer Conferences
4th Annual on Gynecologic Oncology Conference July 18-19, 2018 | Atlanta, USA; ESMO Sarcoma and GIST Symposium 2018 February 5-7, 2018 | Milan, Italy; ASH Meeting on Hematologic Malignancies September 7-8, 2018 | Chicago, IL; Genitourinary Cancers Symposium February 8-10, 2018 | California, USA
Hematology Societies in USA
American Cancer Society, USA; American Brain Tumor Association, USA; Association of Community Cancer Centers, USA; American Childhood Cancer Organization, USA; American Society for Radiation Oncology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; Childhood Brain Tumor Foundation, USA; Michigan Society of Hematology and Oncology, USA; Lymphoma Research Foundation
Track 14: Blood Products:
A blood product may be defined as a therapeutic substance that is acquired from human blood. Some of the blood products are: Whole blood - which is rarely used in transfusion medicine. Blood components - Suspension of red blood cells, white blood cells and platelets; Plasma derivatives - Plasma proteins such as albumin, coagulation factor suspension and immunoglobulins.
Common uses of Blood and its Components:
- Whole Blood - In massive blood loss cases
- Platelets - dengue, leukemia and cancer patients
- Red Blood Cells - anemia
- Fresh Frozen Plasma - Replace clotting factors
Related Conferences:
Blood Disorders Conferences 2018 | Hematology Conferences | World Hematology Congress 2018 | Hematologist oncologist Meet
ESMO Africa Cancer Conference February 14-16, 2018 | Cape Town, South Africa; Hematology Global Summit 2018 September 20-21, 2018 | Bali, Indonesia; World Hematology Conference and Medical Oncology Conference May 28-30, 2018 | Osaka, Japan; Surgical Oncology- Evidence & Practice February 2-3 2018 | Karachi, Pakistan
Hematology Societies in Asia-Pacific
Asian Hematology Association, Asia-Pacific; Asia Pacific Hematology Consortium, Asia-Pacific; Asian Society of Gynecologic Oncology, Asia-Pacific; Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific; Cancer Therapeutics Research Group, Asia-Pacific; Asian Cancer Foundation, Asia-Pacific
Track 15: Hematology Nursing:
Hematology nurses are instructed to provide nursing care to patients with blood diseases or disorders. Duties of the hematology nurse include: Encounter patients with blood diseases i.e. leukemia, haemophilia, sickle cell anemia and lymphoma, Take medical histories, Perform exams, Diagnose and treat blood diseases. They have authority to write prescriptions and order diagnostic laboratory work. Hematology nursing is closely related to oncology nursing.
They may also assist with:
- Blood Tests
- Blood Transfusions
- Research
- Chemotherapy
Related Conferences:
World Hematology Congress | Blood Cancer Event 2018 | Hematology Experts Conferences | Immunohematology Conferences
12th World Hematology Conference March 15-16, 2018 | London, UK; 27th International Oncology research Conference and Cancer Stem Cells Conference May 10-12, 2018 | Frankfurt, Germany; 25th Biennial European Association for Cancer Research Conference June 30-July3 2018 Amsterdam
Hematology Societies in South Africa
Africa Cancer Foundation, Africa; Afrox - Improving Cancer Care in Africa; Oncology for Africa ONLUS - Afron, Africa; South African Clinical Haematology Society, Africa; World Health Organisation - Africa Region; African Organization for Research and Training in Cancer, Africa
Track 16: Pediatric Hematology:
It is a branch of medicine that deals with the cause, diagnosis, treatment and prevention of the diseases related to blood of infants, children and adolescents. Pediatric haematologists/Oncologists are specially trained to treat children with blood disorders and cancer.
- Thalassemia
- Fanconi Anemia
- Sickle Cell Disease
- Congenital Amegakaryocytic Thrombocytopenia
- Dyskeratosis Congenita
- Pediatric anemia
- Pediatric factor VII & XIII diseases
- Hereditary disorders of red cells permeability
- Pediatric myelodysplasia
- Pediatric myelofibrosis
Related Conferences:
Immunohematology Conferences 2018 | Blood Congress | Hematology Meetings | Blood Cancer Events | Hematology Nursing Meet
11th European Breast Cancer Conference Mar 21- 23, 2018 | Barcelona, Spain; 28th Euro Cancer Science Conference and Cancer Therapy Conference August 09-10, 2018 | Madrid, Spain
European Hematology Societies:
European society of Hematology, British Society of Hematology, International society of Hematology, European society of Pediatric Hematology Oncology
Track 17: Haematology and Pharma Industry:
The overall market for the haematological pharmaceuticals in top point as it is as often as possible foreseen to be improved over two or three decades. According to the overall market master, the hematology cure and definite market is depended upon to create at the rate of 7.5% from 2015-2020. A portion of the best drug store enterprises creating Biological Drugs and Generic Drugs fuse. Takeda Oncology, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Novartis, Celgene, Johnson and Johnson, Lilly, Takeda, AstraZeneca, Merck and Co., Amgen, Janssen bio tech, Pfizer, Bayer, Otsuka, Sanofi, Astellas, Eisai, AbbVie, Pharmacyclics, Merck KGaA and Incyte.
Related Conferences:
Blood Disorders Congress 2018 | World Hematology Conferences | Hematologic Oncology Meet | Hematologists Meeting
27th International Conference on Oncology & Cancer Stem Cells Conferences, May 10-12, 2018 Frankfurt, Germany; 9th Molecular Immunology Conferences & Immunogenetics Conferences, March 08-09, 2018 London, UK; 28th Euro Cancer Science Conferences, August 09-10, 2018 Madrid, Spain; 9th European Immunology Conferences, June 14-16, 2018 Rome, Italy;
Hematology Societies in USA
Association of Community Cancer Centers, USA; American Brain Tumor Association, USA; Lymphoma Research Foundation; American Cancer Society, USA; American Childhood Cancer Organization, USA; Michigan Society of Hematology and Oncology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; American Society for Radiation Oncology, USA; Childhood Brain Tumor Foundation, USA
Track 18: Case reports and Epidemiology of Hematology & Hem-Oncology:
A Case report is a complete report of the signs, symptoms, diagnosis, treatment and follow-up of an individual patient. Hematology case reports do have genuinely helpful roles in medical research and evidence-based drugs. Specifically, they need facilitated recognition of recent diseases and adverse effects of treatments. Case reports encourage understanding the clinical range of unique or rare diseases, also as exceptional introductions of normal ailments. Case reports may likewise have an assignment to play in directing the personalization of medicines in clinical take after. For instance, Acquired Thrombotic Thrombocytopenic Purpura in a Patient with Pernicious Anemia was suggested by the report of a specific case.
Related Conferences:
World Hematology 2018 | Bleeding disorders Event | Heme-Oncology Congress | Pediatric Hematology Conferences
World Hematology Conference and Medical Oncology Conference May 28-30, 2018 | Osaka, Japan; ESMO Africa Cancer Conference February 14-16, 2018 | Cape Town, South Africa; Hematology Global Summit 2018 September 20-21, 2018 | Bali, Indonesia; Surgical Oncology- Evidence & Practice February 2-3 2018 | Karachi, Pakistan
Hematology Societies in South Africa
Haematology and Oncology Society of Africa; African Cancer Registry Network, Africa; Mediterranean Oncology Society, Africa; African Women’s Cancer Awareness Association, Africa; Morocco - World Health Organization Africa; South African Society of Haematology, Africa; CHOC Childhood Cancer Foundation, South Africa
Track 19: Erythroblastosis fetalis:
A two blood groups system, that leads to erythroblastosis are Rh and ABO. Rhesus (Rh) is the protein that is inherited which is found over the surface of the red blood cells. People with Rh protein in the blood are Rh positive and without Rh protein are Rh negative. The two main causes of erythroblastosis fetalis: ABO incompatibility and Rh incompatibility.
Complications of erythroblastosis fetalis:
- Rapidly rising bilirubin
- Bilirubin Induced Neurological Dysfunction
- Prolonged hyperbilirubinemia
- Cerebral Palsy
- Neutropenia
- Kernicterus
- Thrombocytopenia
- Hemolytic anemia
Related Conferences:
Immunohematology Conferences 2018 | Blood Congress | Hematology Meetings | Blood Cancer Events | Hematology Nursing Meet
11th European Breast Cancer Conference Mar 21- 23, 2018 | Barcelona, Spain; 28th Euro Cancer Science Conference and Cancer Therapy Conference August 09-10, 2018 | Madrid, Spain
European Hematology Societies:
European society of Hematology, British Society of Hematology, International society of Hematology, European society of Pediatric Hematology Oncology
Track 20: Hemoglobinopathy:
Haemoglobin is the red protein present in the blood that supplies oxygen to tissues in vertebrates. Haemoglobin is produced by genes that control the expression of the haemoglobin protein. Defects in these genes produce abnormal haemoglobins and anemia these conditions are termed as hemoglobinopathy. It is a kind of genetic defect.
Haemoglobin Variants (mutant forms):
- Hb S
- Hb E
- Hb C
- Hb H
- Hb J
Related Conferences:
Blood Disorders Congress 2018 | World Hematology Conferences | Hematologic Oncology Meet | Hematologists Meetings
25th Biennial European Association for Cancer Research Conference June 30-July3 2018 Amsterdam; 27th International Oncology research Conference and Cancer Stem Cells Conference May 10-12, 2018 | Frankfurt, Germany | 12th World Hematology Conference March 15-16, 2018 | London, UK
Hematology Societies in Europe
Association of European Cancer Leagues, Europe; International Society of Pediatric Oncology, Europe; European Academy of Cancer Sciences, Europe; European Society of Surgical Oncology, Europe; Organization of European Cancer Institute, Europe; European Organization for Research and Treatment of Cancer, Europe; European Prostate Cancer Coalition, Europe
Track 21: Hematologic Therapies:
It is the branch of medicine that deals with the study of blood, blood disease and the organs involved in forming blood. The diagnosis and treatment of hematological disorders is mainly managed by specialists in the field referred to as hematologists.
Related Conferences:
Pediatric Hematologist Conferences | Hematology Congress 2018 | Blood conferences | Hematology Events | Blood Diseases Meet
ESMO Africa Cancer Conference February 14-16, 2018 | Cape Town, South Africa; Hematology Global Summit 2018 September 20-21, 2018 | Bali, Indonesia; World Hematology Conference and Medical Oncology Conference May 28-30, 2018 | Osaka, Japan; Surgical Oncology- Evidence & Practice February 2-3 2018 | Karachi, Pakistan
Hematology Societies in Asia-Pacific
Asian Cancer Foundation, Asia-Pacific; Asia Pacific Hematology Consortium, Asia-Pacific; Asian Society of Gynecologic Oncology, Asia-Pacific; Cancer Therapeutics Research Group, Asia-Pacific; Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific; Asian Hematology Association, Asia-Pacific
The Americas told the biggest offer of 45% of the worldwide hematology advertise at an expected $2,160 million out of 2015. Europe told the second biggest offer 26% of hematology advertise at an expected $300 million of every 2015.
The overall hematology feature is isolated into hematology items and organizations. Hematology items promote has been divided into instruments and consumables. The hematology instruments promote is furthermore separated into analyzers and slide strainers/makers. While the hematology consumables publicize has been assembled into three essential areas specifically; authorities, stains, and controls and calibrators. In addition, in light of the end-customers, the overall hematology promote has been separated into business affiliations, stay singular recuperating focuses, investigate associations, and clinical testing labs.
Different variables, for example, change of the high throughput hematology analyzers, growing apportionment of automated hematology instruments by diagnostics explore focuses, combination of basic stream cytometry techniques in current hematology analyzers, inventive degrees of progress and improvements in high affectability motivation behind brain (POC) hematology testing are moving the advancement of the overall hematology analyzers and reagents publicize. Of course, direct appointment of the impelled hematology instruments in the rising economies, hematology thing surveys, and the high cost of hematology analyzers are restricting the improvement of the overall market.
Beginning at 2014, North America holds the greatest offer of the overall market, trailed by Europe. In any case, the Asia-Pacific market is required to create at most significant CAGR of ~9.4% from 2014 to 2019. Different segments including making therapeutic administrations establishment, the broad patient masses, extending sponsoring/wander toward the headway of hematology things and building up a point of convergence of both worldwide and private players on the Asia-Pacific countries are engaging the advancement of the market in the Asia-Pacific locale.
The success of the Hematology conferences has given us the prospect to bring the gathering one more time. Conference series LLC LTD hosted the “7th World Hematologists Congress” during May 08-09, 2017 at Tryp Barcelona Airport, Parque de Negocios Mas Blau II, Plaza Plan Lake, 1-2, 08820 El Prat de Llobregat, Barcelona, Spain. The conference was focused on Hematology & Blood Disorders studies with the theme “A Step towards Excellence in Hematology Research”. The meeting engrossed a vicinity of comprehensive discussions on novel subjects like hematology, hematologic oncology, blood disorders, hematologic disorders, oncology, blood disorders diagnosis and treatment etc.
The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:
- John Batchelor; Central Manchester Foundation Trust, UK
- Mingzhi Zhang; First Affiliated Hospital of Zhengzhou University, China
- Soad KAl Jaouni; King Abdulaziz University, Saudi Arabia
- Jean-Francois Schved; Montpellier University Hospital, France
- M Dahmani Fathallah; Arabian Gulf University, Bahrain
Conference series LLC LTD offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conference series LLC LTD and supported the conference in every aspect, without which the conference would not have been possible.
Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Hematologists 2017, Conference series LLC LTD would like to announce the commencement of the “15th World Hematology Congress” to be held during December 05-06, 2018 at Lisbon, Portugal. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Cancer Research.
Let us meet again @ World Hematology 2018
Conference Highlights
- Immunohematology
- Leukocytosis
- Thrombocytopenia
- Myeloma
- Blood Transfusion
- Anemia
- Thrombosis
- Biomarkers in Hematology and Oncology
- HIV/AIDS
- Lymphoma
- Hemochromatosis
- Stem Cell Therapy
- Blood Tests
- Blood Products
- Hematology Nursing
- Pediatric Hematology
- Haematology and Pharma Industry
- Case reports and Epidemiology of Hematology & Hem-Oncology
- Erythroblastosis fetalis
- Hemoglobinopathy
- Hematologic Therapies
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
Conference Date | December 05-06, 2018 | ||
Sponsors & Exhibitors |
|
||
Speaker Opportunity Closed | |||
Poster Opportunity Closed | Click Here to View |
Useful Links
Special Issues
All accepted abstracts will be published in respective Our International Journals.
- Journal of Blood Disorders & Transfusion
- Jourmal of Blood & Lymph
- Journal of Stem Cell Research & Therapy
Abstracts will be provided with Digital Object Identifier by